| HDL in atherosclerotic cardiovascular disease: in search of a role M Casula, O Colpani, S Xie, AL Catapano, A Baragetti Cells 10 (8), 1869, 2021 | 61 | 2021 |
| Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials S Xie, F Galimberti, E Olmastroni, TF Luscher, S Carugo, AL Catapano, ... Cardiovascular Research 120 (4), 333-344, 2024 | 4 | 2024 |
| USE OF MULTIPLE ANALYTIC APPROACHES TO IDENTIFY NEW MARKERS/RISK FACTORS FOR CARDIOVASCULAR DISEASES AND EVALUATE THEIR ROLE AS POSSIBLE PHARMACOLOGICAL TARGETS S Xie Università degli Studi di Milano, 2024 | | 2024 |
| The XVII National Congress of the Società Italiana di Terapia Clinica e Sperimentale (SITeCS): Conference report-SITeCS 2023 S Xie, M Casula, F Galimberti, A Corsini, AL Catapano European Atherosclerosis Journal 2 (3), 50-51, 2023 | | 2023 |
| Meta-analysis of randomized controlled trials evaluating the effect of PCSK9 inhibitors on lipoprotein (A) levels S Xie, F Galimberti, E Olmastroni, A Catapano, M Casula Atherosclerosis 379, S21, 2023 | | 2023 |
| Effect of lipid-lowering therapies on lipoprotein (a) levels: a meta-analysis of randomized controlled trials: Selected Abstract–Spring Meeting 2023 S Xie, F Galimberti, E Olmastroni, AL Catapano, M Casula European Atherosclerosis Journal 2 (1), 26-26, 2023 | | 2023 |
| Meta-analysis of randomized controlled trials comparing effect of lipid-lowering therapies on C-reactive protein levels S Xie, F Galimberti, E Olmastroni, M Casula, AL Catapano Atherosclerosis 355, 33-34, 2022 | | 2022 |
| Treatment of patients with severe hypercholesterolemia: A meta-analysis of Mipomersen, Lomitapide and Inclisiran O Colpani, E Olmastroni, S Xie, AL Catapano, M Casula Atherosclerosis 331, e260, 2021 | | 2021 |
